FDA’s NAM framework emphasizes context of use, human biological relevance, technical characterization, and fit-for-purpose ...

Incannex Healthcare Inc. (Nasdaq: IXHL) , a clinical-stage biopharmaceutical company developing combination therapies for high-impact indications, today reported that it holds approximately $75 ...

A U.S. intelligence assessment released in March 2026 warns that five countries, including Pakistan, could develop or already ...

Business Development Program, which enables Alaska Native corporations to compete for federal contracts, is under attack. Every Alaskan should be paying attention, because this is about more than how ...

A look at how AJ Sturges, Samantha Leavens and Mike Kostka help players across Chicago and Rockford develop the mental side ...

Acumen Pharmaceuticals (NASDAQ:ABOS) announced that on March 13, 2026 it agreed to sell 10,833,331 common shares at a price ...

Onchilles Pharma, a private biotech company advancing therapeutics targeting the ELANE pathway, today announced that new preclinical data supporting its systemically delivered NEU-002 program will be ...

The American School Counselor Association promoted Lean In Girls, which pushes transgender ideology and critical race theory, ...

Empire State Development (ESD) today announced the 10 startups chosen for round nine of the New York State supported Luminate N ...

The U.S. Food and Drug Administration (FDA)’s March 2026 update to its biosimilar Q&A guidance arrives at a critical inflection point for ...

However, at the end of the season, the scholarship runs out, the career takes a new twist, most athletes go through the rough period of transition, the time when the helmet is taken off. Whereas the ...